• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于诊疗应用的剂量测定软件:当前能力与未来前景

Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects.

作者信息

Kesner Adam L, Brosch-Lenz Julia, Gear Jonathan, Lassmann Michael

机构信息

Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York.

Institute of Nuclear Medicine, Glen Burnie, Maryland.

出版信息

J Nucl Med. 2025 Feb 3;66(2):166-172. doi: 10.2967/jnumed.124.268998.

DOI:10.2967/jnumed.124.268998
PMID:39778969
Abstract

Dosimetry is integral to informed implementation of radiopharmaceutical therapies, enabling personalized treatment planning and ensuring patient safety by calculating absorbed doses to organs and tumors. As the therapeutic radiopharmaceutical field continues to expand, dosimetry software has emerged as a crucial tool for optimization of treatment efficacy. This review discusses key features and capabilities that current dosimetry software solutions have or should have in the future. We highlight the need for standardization across platforms to support consistent and accurate dose calculations. Furthermore, we explore opportunities for advancing software, such as incorporating biologically effective dose modeling and improving uncertainty quantification. Looking ahead, we advocate for expanding infrastructure for open data sets and fostering ongoing collaboration between vendors and end users to guide the field toward greater integration and efficacy.

摘要

剂量测定对于放射性药物治疗的明智实施至关重要,它通过计算器官和肿瘤的吸收剂量来实现个性化治疗规划并确保患者安全。随着治疗性放射性药物领域的不断扩展,剂量测定软件已成为优化治疗效果的关键工具。本综述讨论了当前剂量测定软件解决方案现有的或未来应具备的关键特性和功能。我们强调跨平台标准化的必要性,以支持一致且准确的剂量计算。此外,我们探索软件改进的机会,例如纳入生物有效剂量建模和改进不确定性量化。展望未来,我们主张扩展开放数据集的基础设施,并促进供应商与终端用户之间的持续合作,以引导该领域实现更大程度的整合与更高的效能。

相似文献

1
Dosimetry Software for Theranostic Applications: Current Capabilities and Future Prospects.用于诊疗应用的剂量测定软件:当前能力与未来前景
J Nucl Med. 2025 Feb 3;66(2):166-172. doi: 10.2967/jnumed.124.268998.
2
Do we need dosimetry for the optimization of theranostics in CNS tumors?在中枢神经系统肿瘤的诊疗一体化优化中,我们是否需要剂量测定法?
Neuro Oncol. 2024 Dec 9;26(Supplement_9):S242-S258. doi: 10.1093/neuonc/noae200.
3
A Phase I/II Study of [Lu]Lu-HTK03170 with Personalized Dosimetry in Patients with Metastatic Castration-Resistant Prostate Cancer: Clinical Trial Protocol.一项针对转移性去势抵抗性前列腺癌患者进行的[镥]Lu-HTK03170个体化剂量测定的I/II期研究:临床试验方案。
J Nucl Med. 2025 Jul 1;66(7):1061-1067. doi: 10.2967/jnumed.124.269064.
4
Dosimetrically coupled multiscale tetrahedral mesh models of human liver vasculature: implications for radiopharmaceutical dosimetry of both organ blood and parenchyma.人体肝脏血管系统的剂量耦合多尺度四面体网格模型:对器官血液和实质放射性药物剂量测定的影响。
Phys Med Biol. 2025 Jun 19;70(12). doi: 10.1088/1361-6560/addfa6.
5
MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic Radiopharmaceuticals.MIRD 手册第 28 号,第 2 部分:在一系列诊断放射性药物中比较 MIRDcalc 剂量计算软件的评估。
J Nucl Med. 2023 Aug;64(8):1295-1303. doi: 10.2967/jnumed.122.264230. Epub 2023 Jun 2.
6
The risk index as a basis for risk/benefit analyses and protocol optimization in diagnostic nuclear imaging.风险指数作为诊断核成像中风险/效益分析和方案优化的基础。
Med Phys. 2023 Dec;50(12):7390-7399. doi: 10.1002/mp.16696. Epub 2023 Sep 1.
7
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.
8
The use of Open Dialogue in Trauma Informed Care services for mental health consumers and their family networks: A scoping review.创伤知情护理服务中使用开放对话模式为心理健康消费者及其家庭网络提供服务:范围综述。
J Psychiatr Ment Health Nurs. 2024 Aug;31(4):681-698. doi: 10.1111/jpm.13023. Epub 2024 Jan 17.
9
An International Study of Factors Affecting Variability of Dosimetry Calculations, Part 3: Contribution from Calculating Absorbed Dose from Time-Integrated Activity.一项关于影响剂量计算变异性因素的国际研究,第3部分:从时间积分活度计算吸收剂量的贡献。
J Nucl Med. 2024 Aug 1;65(8):1166-1172. doi: 10.2967/jnumed.123.267293.
10
MIRD Pamphlet No. 30: MIRDfit-A Tool for Fitting of Biodistribution Time-Activity Data for Internal Dosimetry.MIRD 手册第 30 号:MIRDfit——用于拟合内部剂量学生物分布时间-活性数据的工具。
J Nucl Med. 2024 Nov 1;65(11):1808-1814. doi: 10.2967/jnumed.124.268011.

引用本文的文献

1
A proof-of-concept study of personalized dosimetry for targeted radioligand therapy using pre-treatment diagnostic dynamic PET/CT and Monte Carlo simulation.一项使用治疗前诊断性动态PET/CT和蒙特卡洛模拟进行靶向放射性配体治疗个性化剂量测定的概念验证研究。
Front Oncol. 2025 Aug 4;15:1600821. doi: 10.3389/fonc.2025.1600821. eCollection 2025.
2
Evaluation of end-to-end 3D absorbed dose distribution in Y-SIRT and SBRT combination therapy using MAGIC-f polymer gel dosimeter.使用MAGIC-f聚合物凝胶剂量计评估Y-SIRT与SBRT联合治疗中的端到端三维吸收剂量分布。
Eur J Nucl Med Mol Imaging. 2025 Aug 8. doi: 10.1007/s00259-025-07461-2.